Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.32 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.32 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.32 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL60696 | 0.84 | GABRA1 (0.38) | FAAHCA1CA2LMNACYP1A2 | |
| SCHEMBL4076318 | 0.81 | FAAH (0.30) | FAAHCA1CA2LMNACYP1A2 | |
| SCHEMBL1070040 | 0.78 | — | — | |
| SCHEMBL6311798 | 0.78 | FAAH (0.31) | FAAHCA1CA2LMNACYP1A2 | |
| SCHEMBL8074869 | 0.78 | TSHR (0.36) | TSHR | |
| SCHEMBL29205117 | 0.75 | FAAH (0.32) | FAAHCA1CA2LMNACYP1A2 | |
| SCHEMBL19280 | 0.74 | — | — | |
| SCHEMBL2698492 | 0.73 | CYP1A2 (0.31) | FAAHCA1CA2LMNACYP1A2 | |
| SCHEMBL16553560 | 0.73 | FAAH (0.31) | FAAHCA1CA2LMNACYP1A2 | |
| SCHEMBL7548863 | 0.73 | GABRA1 (0.41) | FAAHCA1CA2LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 573 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11958042-B2 | Reactions of olefin derivatives in the presence of metathesis catalysts | UMICORE AG & CO. KG (DE) | 2024-04-16 | — | — | US | claimed |
| US-11794179-B2 | Synthesis and characterization of metathesis catalysts | UMICORE AG & CO. KG | 2023-10-24 | — | — | US | claimed |
| EP-4194092-A1 | SYNTHESIS AND CHARACTERIZATION OF METATHESIS CATALYSTS | Umicore AG & Co. KG (DE) | 2023-06-14 | — | — | EP | claimed |
| EP-3496855-B1 | METATHESIS CATALYSTS | UMICORE AG & CO KG (DE) | 2023-01-18 | — | — | EP | claimed |
| EP-3503999-B1 | SYNTHESIS AND CHARACTERIZATION OF METATHESIS CATALYSTS | UMICORE AG & CO KG (DE) | 2022-12-07 | — | — | EP | claimed |
| CN-109862963-B | Synthesis and characterization of Ru alkylidene complexes | 优美科股份公司及两合公司 | 2022-05-24 | — | — | CN | claimed |
| CN-109641198-B | Synthesis and characterization of metathesis catalysts | 优美科股份公司及两合公司 | 2022-04-12 | — | — | CN | claimed |
| US-20220055025-A1 | REACTIONS OF OLEFIN DERIVATIVES IN THE PRESENCE OF METHATHESIS CATALYSTS | UMICORE AG & CO. KG (DE) | 2022-02-24 | — | — | US | claimed |
| US-11173476-B2 | Metathesis catalysts | UMICORE AG & CO. KG | 2021-11-16 | — | — | US | claimed |
| US-11161104-B2 | Reactions of olefin derivatives in the presence of methathesis catalysts | UMICORE AG & CO. KG | 2021-11-02 | — | — | US | claimed |
| EP-1979342-A1 | COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF | Jerini AG (DE) | 2008-10-15 | — | — | EP | claimed |
| WO-2008070934-A1 | INHIBITION OF INVERTEBRATES USING LIGANDS THAT MODULATE ECDYSONE RECEPTORS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2008-06-19 | — | — | WO | claimed |
| WO-2008070891-A1 | LIGANDS FOR THE MODULATION OF ECDYSONE RECEPTORS AND CONTROL OF INSECT GROWTH | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2008-06-19 | — | — | WO | claimed |
| US-20080004459-A1 | Diimine metal complexes, methods of synthesis, and methods of using in oligomerization and polymerization | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2008-01-03 | — | — | US | claimed |
| WO-2007131764-A2 | NEW HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF | JERINI AG (DE) | 2007-11-22 | — | — | WO | claimed |
| WO-2007088041-A1 | COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF | JERINI AG (DE) | 2007-08-09 | — | — | WO | claimed |
| EP-1377589-B1 | OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2005-09-07 | — | — | EP | claimed |
| CN-1465600-A | Process for preparing additively structured polynorbornene | 中国科学院化学研究所 | 2004-01-07 | — | — | CN | claimed |
| EP-1301512-A2 | BICYCLIC HYDANTOIN DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | LION Bioscience AG (DE) | 2003-04-16 | — | — | EP | claimed |
| WO-2002008227-A2 | BICYCLIC HYDANTOIN DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | LION BIOSCIENCE AG (DE) | 2002-01-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11161104-B2 | Reactions of olefin derivatives in the presence of methathesis catalysts | MDK, MTR, MUSK | FAAH 1308/4885CA1 3731/4885CA2 4594/4885 |
| US-11173476-B2 | Metathesis catalysts | SQLE, FDFT1, COASY | FAAH 263/4885CA1 3161/4885CA2 3866/4885 |
| US-20220055025-A1 | REACTIONS OF OLEFIN DERIVATIVES IN THE PRESENCE OF METHATHESIS CATALYSTS | MDK, MTR, MUSK | FAAH 1308/4885CA1 3731/4885CA2 4594/4885 |
| US-11794179-B2 | Synthesis and characterization of metathesis catalysts | SQLE, FDFT1, FASN | FAAH 238/4885CA1 2955/4885CA2 3644/4885 |
| US-11958042-B2 | Reactions of olefin derivatives in the presence of metathesis catalysts | SYMPK, MDK, HCK | FAAH 2056/4885CA1 3425/4885CA2 4518/4885 |
| US-20080004459-A1 | Diimine metal complexes, methods of synthesis, and methods of using in oligomerization and polymerization | PICALM, AP1M1, AP2M1 | FAAH 3484/4885CA1 1076/4885CA2 666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.